Abstract

Recent advances in genomics have greatly expanded the spectrum of primary immune deficiencies (PIDs). Along with the identification of pathogenic variants in novel genes, distinct phenotypes have been associated with different variants in the same gene. Although PIDs have been historically defined based on increased susceptibility to infections, immune dysregulation has emerged as a frequent and in some cases, predominant phenotype. Autoimmune cytopenias with onset in childhood, lasting longer than 12 months, and affecting multiple lineages should raise the suspicion of a possible PID with monogenic origin. Characterization of the various molecular and cellular mechanisms responsible for these unusual manifestations of PIDs, although at times resource intensive, may allow for targeted intervention in many of them.

References

References
1.
Picard
C
,
Gaspar
HB
,
Al-Herz
W
, et al
.
International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee report on inborn errors of immunity
.
J Clin Immunol
.
2018
;
38
(
1
):
96
-
128
.
2.
Fischer
A
,
Provot
J
,
Jais
JP
,
Alcais
A
,
Mahlaoui
N
;
members of the CEREDIH French PID study group
.
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
.
J Allergy Clin Immunol
.
2017
;
140
(
5
):
1388
-
1393
.
3.
Hadjadj
J
,
Aladjidi
N
,
Fernandes
H
, et al
;
members of the French Reference Center for Pediatric Autoimmune Cytopenia (CEREVANCE)
.
Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes
.
Blood
.
2019
;
134
(
1
):
9
-
21
.
4.
Cunningham-Rundles
C
.
Common variable immune deficiency: dissection of the variable
.
Immunol Rev
.
2019
;
287
(
1
):
145
-
161
.
5.
Meynier
S
,
Rieux-Laucat
F
.
FAS and RAS related apoptosis defects: from autoimmunity to leukemia
.
Immunol Rev
.
2019
;
287
(
1
):
50
-
61
.
6.
Oliveira
JB
,
Bidère
N
,
Niemela
JE
, et al
.
NRAS mutation causes a human autoimmune lymphoproliferative syndrome
.
Proc Natl Acad Sci USA
.
2007
;
104
(
21
):
8953
-
8958
.
7.
Niemela
JE
,
Lu
L
,
Fleisher
TA
, et al
.
Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis
.
Blood
.
2011
;
117
(
10
):
2883
-
2886
.
8.
Rao
VK
.
Approaches to managing autoimmune cytopenias in novel immunological disorders with genetic underpinnings like autoimmune lymphoproliferative syndrome
.
Front Pediatr
.
2015
;
3
:
65
.
9.
Magerus-Chatinet
A
,
Stolzenberg
MC
,
Loffredo
MS
, et al
.
FAS-L, IL-10, and double-negative CD4 CD8 TCR α/β+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function
.
Blood
.
2009
;
113
(
13
):
3027
-
3030
.
10.
Rudman Spergel
A
,
Walkovich
K
,
Price
S
, et al
.
Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis
.
Pediatrics
.
2013
;
132
(
5
):
e1440
-
e1444
.
11.
Calvo
KR
,
Price
S
,
Braylan
RC
, et al
.
JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities
.
Blood
.
2015
;
125
(
18
):
2753
-
2758
.
12.
Kuehn
HS
,
Ouyang
W
,
Lo
B
, et al
.
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
.
Science
.
2014
;
345
(
6204
):
1623
-
1627
.
13.
Schubert
D
,
Bode
C
,
Kenefeck
R
, et al
.
Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations
.
Nat Med
.
2014
;
20
(
12
):
1410
-
1416
.
14.
Lo
B
,
Fritz
JM
,
Su
HC
,
Uzel
G
,
Jordan
MB
,
Lenardo
MJ
.
CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency
.
Blood
.
2016
;
128
(
8
):
1037
-
1042
.
15.
Young
NS
.
Aplastic anemia
.
N Engl J Med
.
2018
;
379
(
17
):
1643
-
1656
.
16.
Schwab
C
,
Gabrysch
A
,
Olbrich
P
, et al
.
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
.
J Allergy Clin Immunol
.
2018
;
142
(
6
):
1932
-
1946
.
17.
Lo
B
,
Zhang
K
,
Lu
W
, et al
.
AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy
.
Science
.
2015
;
349
(
6246
):
436
-
440
.
18.
Lucas
CL
,
Kuehn
HS
,
Zhao
F
, et al
.
Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency
.
Nat Immunol
.
2014
;
15
(
1
):
88
-
97
.
19.
Deau
MC
,
Heurtier
L
,
Frange
P
, et al
.
A human immunodeficiency caused by mutations in the PIK3R1 gene
.
J Clin Invest
.
2015
;
125
(
4
):
1764
-
1765
.
20.
Lucas
CL
,
Zhang
Y
,
Venida
A
, et al
.
Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K
.
J Exp Med
.
2014
;
211
(
13
):
2537
-
2547
.
21.
Rao
VK
,
Webster
S
,
Dalm
VASH
, et al
.
Effective “activated PI3Kδ syndrome”-targeted therapy with the PI3Kδ inhibitor leniolisib
.
Blood
.
2017
;
130
(
21
):
2307
-
2316
.
22.
Rao
VK
,
Webster
S
,
Dalm
VA
, et al
.
Safety and efficacy of long-term suppression of PI3kinase pathway by small molecule PI3K-delta inhibitor, leniolisib in Apds (activated PI3Kδ syndrome)
.
Blood
.
2018
;
132
(
suppl 1
):
3706
.
23.
Barzaghi
F
,
Amaya Hernandez
LC
,
Neven
B
, et al
.
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study
.
J Allergy Clin Immunol
.
2018
;
141
(
3
):
1036
-
1049
.
24.
Oliveira
JB
,
Bleesing
JJ
,
Dianzani
U
, et al
.
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop
.
Blood
.
2010
;
116
(
14
):
e35
-
e40
.
25.
Gambineri
E
,
Ciullini Mannurita
S
,
Hagin
D
, et al
.
Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, x-linked (IPEX) syndrome
.
Front Immunol
.
2018
;
9
:
2411
.
26.
Cepika
AM
,
Sato
Y
,
Liu
JM
,
Uyeda
MJ
,
Bacchetta
R
,
Roncarolo
MG
.
Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency
.
J Allergy Clin Immunol
.
2018
;
142
(
6
):
1679
-
1695
.
27.
Caudy
AA
,
Reddy
ST
,
Chatila
T
,
Atkinson
JP
,
Verbsky
JW
.
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes
.
J Allergy Clin Immunol
.
2007
;
119
(
2
):
482
-
487
.
28.
Zhang
Z
,
Gothe
F
,
Pennamen
P
, et al
.
Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance
.
J Exp Med
.
2019
;
216
(
6
):
1311
-
1327
.
29.
Fernandez
IZ
,
Baxter
RM
,
Garcia-Perez
JE
, et al
.
A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation [published correction appears in J Exp Med. 2019;216(6):1465]
.
J Exp Med
.
2019
;
216
(
6
):
1255
-
1267
.
30.
Flanagan
SE
,
Haapaniemi
E
,
Russell
MA
, et al
.
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
.
Nat Genet
.
2014
;
46
(
8
):
812
-
814
.
31.
Delmonte
OM
,
Schuetz
C
,
Notarangelo
LD
.
RAG deficiency: two genes, many diseases
.
J Clin Immunol
.
2018
;
38
(
6
):
646
-
655
.
32.
Villa
A
,
Notarangelo
LD
.
RAG gene defects at the verge of immunodeficiency and immune dysregulation
.
Immunol Rev
.
2019
;
287
(
1
):
73
-
90
.
33.
Farmer
JR
,
Foldvari
Z
,
Ujhazi
B
, et al
.
Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency
.
J Allergy Clin Immunol Pract
.
2019
;
7
(
6
):
1970
-
1985.e4
.
34.
Notarangelo
LD
.
Combined immunodeficiencies with nonfunctional T lymphocytes
.
Adv Immunol
.
2014
;
121
:
121
-
190
.
35.
Chan
AY
,
Punwani
D
,
Kadlecek
TA
, et al
.
A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70
.
J Exp Med
.
2016
;
213
(
2
):
155
-
165
.
36.
Toubiana
J
,
Okada
S
,
Hiller
J
, et al
;
International STAT1 Gain-of-Function Study Group
.
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
.
Blood
.
2016
;
127
(
25
):
3154
-
3164
.
37.
Leiding
JW
,
Okada
S
,
Hagin
D
, et al
.
Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations
.
J Allergy Clin Immunol
.
2018
;
141
(
2
):
704
-
717
.
38.
Forbes
LR
,
Vogel
TP
,
Cooper
MA
, et al
.
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
.
J Allergy Clin Immunol
.
2018
;
142
(
5
):
1665
-
1669
.
You do not currently have access to this content.